- Report
- July 2024
- 151 Pages
Global
From €3766EUR$4,250USD£3,243GBP
- Report
- July 2025
- 150 Pages
Global
From €3500EUR$3,950USD£3,014GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- June 2025
- 400 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- October 2024
- 200 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- October 2024
- 200 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- August 2024
- 200 Pages
Global
From €3429EUR$3,869USD£2,953GBP
- Report
- December 2024
- 204 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- May 2025
- 222 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- May 2025
- 220 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- March 2025
- 243 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- January 2025
- 194 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- December 2024
- 196 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- September 2024
- 173 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- July 2025
Global
From €1857EUR$2,095USD£1,599GBP
€3536EUR$3,990USD£3,045GBP
- Report
- July 2025
- 477 Pages
Global
From €5184EUR$5,850USD£4,465GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more